Shares of Plexus Corp. (NASDAQ:PLXS - Get Free Report) have earned a consensus rating of "Moderate Buy" from the five ratings firms that are covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 month target price among analysts that have covered the stock in the last year is $152.00.
PLXS has been the subject of several research analyst reports. Benchmark reiterated a "buy" rating and issued a $160.00 price objective on shares of Plexus in a research report on Wednesday, June 4th. Wall Street Zen lowered Plexus from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 16th. Stifel Nicolaus set a $140.00 price objective on Plexus in a research report on Thursday, July 24th. Sidoti upgraded Plexus from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $135.00 to $150.00 in a research report on Friday, July 25th. Finally, Needham & Company LLC decreased their price objective on Plexus from $162.00 to $158.00 and set a "buy" rating for the company in a research report on Thursday, July 24th.
Check Out Our Latest Report on PLXS
Insider Transactions at Plexus
In other Plexus news, COO Oliver K. Mihm sold 2,102 shares of the company's stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $130.43, for a total transaction of $274,163.86. Following the completion of the transaction, the chief operating officer owned 21,155 shares of the company's stock, valued at $2,759,246.65. This represents a 9.04% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CAO Angelo Michael Ninivaggi, Jr. sold 1,576 shares of the company's stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $137.78, for a total value of $217,141.28. Following the transaction, the chief accounting officer directly owned 24,495 shares of the company's stock, valued at approximately $3,374,921.10. This trade represents a 6.05% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 14,356 shares of company stock worth $1,926,890. Corporate insiders own 1.76% of the company's stock.
Hedge Funds Weigh In On Plexus
A number of large investors have recently bought and sold shares of the company. Huntington National Bank boosted its position in Plexus by 41.5% during the 2nd quarter. Huntington National Bank now owns 324 shares of the technology company's stock worth $44,000 after acquiring an additional 95 shares during the last quarter. Xponance Inc. boosted its position in Plexus by 4.8% during the 1st quarter. Xponance Inc. now owns 2,315 shares of the technology company's stock worth $297,000 after acquiring an additional 106 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its position in Plexus by 7.1% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,750 shares of the technology company's stock worth $237,000 after acquiring an additional 116 shares during the last quarter. Inspire Investing LLC raised its stake in shares of Plexus by 4.8% during the 1st quarter. Inspire Investing LLC now owns 2,682 shares of the technology company's stock worth $344,000 after purchasing an additional 123 shares in the last quarter. Finally, Yousif Capital Management LLC raised its stake in shares of Plexus by 1.2% during the 2nd quarter. Yousif Capital Management LLC now owns 10,117 shares of the technology company's stock worth $1,369,000 after purchasing an additional 124 shares in the last quarter. Institutional investors and hedge funds own 94.45% of the company's stock.
Plexus Price Performance
Plexus stock opened at $138.06 on Friday. The firm has a market capitalization of $3.73 billion, a P/E ratio of 23.52 and a beta of 0.82. Plexus has a 1 year low of $103.43 and a 1 year high of $172.89. The business has a 50-day moving average of $133.29 and a 200-day moving average of $129.95. The company has a current ratio of 1.58, a quick ratio of 0.74 and a debt-to-equity ratio of 0.06.
Plexus (NASDAQ:PLXS - Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The technology company reported $1.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.19. Plexus had a return on equity of 12.33% and a net margin of 4.04%.The business had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.02 billion. During the same period in the previous year, the firm earned $1.45 EPS. Plexus's quarterly revenue was up 6.0% compared to the same quarter last year. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. On average, equities analysts anticipate that Plexus will post 5.9 EPS for the current year.
Plexus Company Profile
(
Get Free Report)
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Plexus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.
While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.